Originally developed as an oral medication for severe hypertension in the 1970s, researchers noticed an unexpected side effect: patients were experiencing hair growth on their scalps and bodies
Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer
Future research objectives must concentrate on creating prediction algorithms for appropriate receptor targeting ratios, exploring triple-agonist strategies (GLP-1/GIP/glucagon), and determining long-term safety profiles for multi-receptor therapies
it builds a franchise diabetes, obesity, heart disease, kidney disease, NASH, etc.each indication creating new revenue streams.[13][25][2] 5.2 Branding and Segmentation Ozempic is sold as a diabetes drug, Wegovy as a specialist obesity treatment, and Rybelsus as a convenient oral option
ulg